Further evaluation of amniotic membrane banking for transplantation in ocular surface diseases

Paolo Rama, Roberta Giannini, Alessandro Bruni, Claudio Gatto, Roberta Tiso, Diego Ponzin

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objective: To define the best conditions for amniotic membrane preparation, storage and banking in its use for corneal reconstruction. Methods: Amniotic membrane pieces were prepared under sterile conditions from placentas selected on the basis of donor medical and social history, serology, microbiological tests and histology. The pieces were kept at - 140 °C but before grafting they were thawed and stored at 4 °C in RPMI medium, to have a preparation usable within 72 h. This procedure was validated by testing its therapeutic effectiveness in 25 patients 13 of which had corneal ulcers of various origin, 3 had sequelae of herpes simplex keratitis, 3 band keratopathy and 6 corneal stem cell deficiency due to chemical or thermal burns. Results: The preparation showed appreciable anti-inflammatory and analgesic effects. In the absence of corneal stem cell deficiency a stable re-epithelialisation was achieved in 15 out of 19 patients. When the limbus was lesioned, the amniotic membrane decreased vascularization and increased the number of corneal epithelial cells only in 1 of the 6 patients. No adverse reactions attributable to the tissue were recorded. Conclusions: A ready-to-use amniotic membrane preparation stored at 4 °C after cryopreservation has been tested in corneal reconstruction. Like the amniotic membrane thawed immediately before grafting, this preparation displayed full therapeutic effect in epithelial defects with stromal ulceration but without severe limbal stem cell deficiency. In two years banking activity 463 pieces of the preparation were successfully distributed to 90 Italian hospitals.

Original languageEnglish
Pages (from-to)155-163
Number of pages9
JournalCell and Tissue Banking
Volume2
Issue number3
DOIs
Publication statusPublished - 2001

Fingerprint

Amnion
Eye Diseases
Transplantation
Membranes
Stem cells
Stem Cells
Re-Epithelialization
Herpetic Keratitis
Corneal Ulcer
Histology
Cryopreservation
Non-Steroidal Anti-Inflammatory Agents
Therapeutic Uses
Serology
Burns
Placenta
Hot Temperature
History
Epithelial Cells
Tissue Donors

Keywords

  • Amniotic membrane
  • Band keratopathy
  • Cornea epithelialization
  • Cornea reconstruction
  • Corneal ulcers
  • Herpes simplex keratitis
  • Limbal stem cell deficiency

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Further evaluation of amniotic membrane banking for transplantation in ocular surface diseases. / Rama, Paolo; Giannini, Roberta; Bruni, Alessandro; Gatto, Claudio; Tiso, Roberta; Ponzin, Diego.

In: Cell and Tissue Banking, Vol. 2, No. 3, 2001, p. 155-163.

Research output: Contribution to journalArticle

Rama, Paolo ; Giannini, Roberta ; Bruni, Alessandro ; Gatto, Claudio ; Tiso, Roberta ; Ponzin, Diego. / Further evaluation of amniotic membrane banking for transplantation in ocular surface diseases. In: Cell and Tissue Banking. 2001 ; Vol. 2, No. 3. pp. 155-163.
@article{e3097722149c4a1482843c95c80d8af4,
title = "Further evaluation of amniotic membrane banking for transplantation in ocular surface diseases",
abstract = "Objective: To define the best conditions for amniotic membrane preparation, storage and banking in its use for corneal reconstruction. Methods: Amniotic membrane pieces were prepared under sterile conditions from placentas selected on the basis of donor medical and social history, serology, microbiological tests and histology. The pieces were kept at - 140 °C but before grafting they were thawed and stored at 4 °C in RPMI medium, to have a preparation usable within 72 h. This procedure was validated by testing its therapeutic effectiveness in 25 patients 13 of which had corneal ulcers of various origin, 3 had sequelae of herpes simplex keratitis, 3 band keratopathy and 6 corneal stem cell deficiency due to chemical or thermal burns. Results: The preparation showed appreciable anti-inflammatory and analgesic effects. In the absence of corneal stem cell deficiency a stable re-epithelialisation was achieved in 15 out of 19 patients. When the limbus was lesioned, the amniotic membrane decreased vascularization and increased the number of corneal epithelial cells only in 1 of the 6 patients. No adverse reactions attributable to the tissue were recorded. Conclusions: A ready-to-use amniotic membrane preparation stored at 4 °C after cryopreservation has been tested in corneal reconstruction. Like the amniotic membrane thawed immediately before grafting, this preparation displayed full therapeutic effect in epithelial defects with stromal ulceration but without severe limbal stem cell deficiency. In two years banking activity 463 pieces of the preparation were successfully distributed to 90 Italian hospitals.",
keywords = "Amniotic membrane, Band keratopathy, Cornea epithelialization, Cornea reconstruction, Corneal ulcers, Herpes simplex keratitis, Limbal stem cell deficiency",
author = "Paolo Rama and Roberta Giannini and Alessandro Bruni and Claudio Gatto and Roberta Tiso and Diego Ponzin",
year = "2001",
doi = "10.1023/A:1020158206073",
language = "English",
volume = "2",
pages = "155--163",
journal = "Cell and Tissue Banking",
issn = "1389-9333",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Further evaluation of amniotic membrane banking for transplantation in ocular surface diseases

AU - Rama, Paolo

AU - Giannini, Roberta

AU - Bruni, Alessandro

AU - Gatto, Claudio

AU - Tiso, Roberta

AU - Ponzin, Diego

PY - 2001

Y1 - 2001

N2 - Objective: To define the best conditions for amniotic membrane preparation, storage and banking in its use for corneal reconstruction. Methods: Amniotic membrane pieces were prepared under sterile conditions from placentas selected on the basis of donor medical and social history, serology, microbiological tests and histology. The pieces were kept at - 140 °C but before grafting they were thawed and stored at 4 °C in RPMI medium, to have a preparation usable within 72 h. This procedure was validated by testing its therapeutic effectiveness in 25 patients 13 of which had corneal ulcers of various origin, 3 had sequelae of herpes simplex keratitis, 3 band keratopathy and 6 corneal stem cell deficiency due to chemical or thermal burns. Results: The preparation showed appreciable anti-inflammatory and analgesic effects. In the absence of corneal stem cell deficiency a stable re-epithelialisation was achieved in 15 out of 19 patients. When the limbus was lesioned, the amniotic membrane decreased vascularization and increased the number of corneal epithelial cells only in 1 of the 6 patients. No adverse reactions attributable to the tissue were recorded. Conclusions: A ready-to-use amniotic membrane preparation stored at 4 °C after cryopreservation has been tested in corneal reconstruction. Like the amniotic membrane thawed immediately before grafting, this preparation displayed full therapeutic effect in epithelial defects with stromal ulceration but without severe limbal stem cell deficiency. In two years banking activity 463 pieces of the preparation were successfully distributed to 90 Italian hospitals.

AB - Objective: To define the best conditions for amniotic membrane preparation, storage and banking in its use for corneal reconstruction. Methods: Amniotic membrane pieces were prepared under sterile conditions from placentas selected on the basis of donor medical and social history, serology, microbiological tests and histology. The pieces were kept at - 140 °C but before grafting they were thawed and stored at 4 °C in RPMI medium, to have a preparation usable within 72 h. This procedure was validated by testing its therapeutic effectiveness in 25 patients 13 of which had corneal ulcers of various origin, 3 had sequelae of herpes simplex keratitis, 3 band keratopathy and 6 corneal stem cell deficiency due to chemical or thermal burns. Results: The preparation showed appreciable anti-inflammatory and analgesic effects. In the absence of corneal stem cell deficiency a stable re-epithelialisation was achieved in 15 out of 19 patients. When the limbus was lesioned, the amniotic membrane decreased vascularization and increased the number of corneal epithelial cells only in 1 of the 6 patients. No adverse reactions attributable to the tissue were recorded. Conclusions: A ready-to-use amniotic membrane preparation stored at 4 °C after cryopreservation has been tested in corneal reconstruction. Like the amniotic membrane thawed immediately before grafting, this preparation displayed full therapeutic effect in epithelial defects with stromal ulceration but without severe limbal stem cell deficiency. In two years banking activity 463 pieces of the preparation were successfully distributed to 90 Italian hospitals.

KW - Amniotic membrane

KW - Band keratopathy

KW - Cornea epithelialization

KW - Cornea reconstruction

KW - Corneal ulcers

KW - Herpes simplex keratitis

KW - Limbal stem cell deficiency

UR - http://www.scopus.com/inward/record.url?scp=0035760515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035760515&partnerID=8YFLogxK

U2 - 10.1023/A:1020158206073

DO - 10.1023/A:1020158206073

M3 - Article

VL - 2

SP - 155

EP - 163

JO - Cell and Tissue Banking

JF - Cell and Tissue Banking

SN - 1389-9333

IS - 3

ER -